The maintenance of a Buy rating combined with an increased price target suggests a strong confidence in ANI Pharmaceuticals' future performance. This is likely to be viewed positively by investors, potentially leading to a short-term increase in stock price as market sentiment aligns with the analyst's positive outlook.